PBH - Prestige Consumer Healthcare Inc.
Close
78.11
-0.175 -0.224%
Share volume: 4,328
Last Updated: Fri 27 Dec 2024 08:30:13 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$78.28
-0.18
-0.22%
Fundamental analysis
66%
Profitability
48%
Dept financing
42%
Liquidity
69%
Performance
90%
Performance
5 Days
0.85%
1 Month
-5.87%
3 Months
11.09%
6 Months
13.80%
1 Year
28.08%
2 Year
24.63%
Key data
Stock price
$78.11
DAY RANGE
$77.78 - $79.38
52 WEEK RANGE
$58.95 - $86.36
52 WEEK CHANGE
$29.42
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Ronald M. Lombardi
Region: US
Website: prestigebrands.com
Employees: 540
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: prestigebrands.com
Employees: 540
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies.
Recent news